Pentam and Guaifenesin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pentam (pentamidine isethionate) and Guaifenesin (guaifenesin). Common drug interactions include hypoxia among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Pentam and Guaifenesin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Pentam?
Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.
What is Guaifenesin?
Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.
16 people who take Pentam and Guaifenesin together, and have interactions are studied.

What are the common drug interactions of Pentam and Guaifenesin, by gender? *:
female:
- Hypoxia (low oxygen in tissues)
- Infection
- Platelet count decreased
- Pneumonia
- Diabetes mellitus inadequate control
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Acute respiratory failure
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Aspergillosis (an infection caused by a fungus called aspergillus)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
male:
- Diarrhoea
- Renal failure (kidney dysfunction)
- Contusion (a type of hematoma of tissue in which capillaries)
- Drug maladministration
- Epistaxis (bleed from the nose)
- Face oedema (swelling of face)
- Fall
- Fatigue (feeling of tiredness)
- Muscle spasms (muscle contraction)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
What are the common drug interactions of Pentam and Guaifenesin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Renal failure (kidney dysfunction)
- Dyspnoea (difficult or laboured respiration)
- Hypoxia (low oxygen in tissues)
- Somnolence (a state of near-sleep, a strong desire for sleep)
20-29:
n/a
30-39:
n/a
40-49:
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Blood creatinine increased
- Cardiac ventricular disorder (ventricular dysfunction of heart)
- Conduction disorder (serious disorder of the heart not responses proper to impulses)
- Constipation
- Culture urine positive
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Electrocardiogram st-t change
50-59:
- Acute respiratory failure
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Aspergillosis (an infection caused by a fungus called aspergillus)
- Blood disorder
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Death
- Drug maladministration
60+:
- Diarrhoea
- Blood bilirubin increased
- Fall
- Fatigue (feeling of tiredness)
- Malignant neoplasm progression (cancer tumour came back)
- Muscle spasms (muscle contraction)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Platelet count decreased
- Pneumonia
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
What are the existing conditions these people have? *
- Constipation: 5 people, 31.25%
- Pain: 5 people, 31.25%
- Hypokalemia (low potassium): 4 people, 25.00%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 25.00%
- Rashes (redness): 3 people, 18.75%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 18.75%
- Pneumonia: 3 people, 18.75%
- Leukaemia (blood or bone marrow cancer): 2 people, 12.50%
- Nausea (feeling of having an urge to vomit): 2 people, 12.50%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Pentam and Guaifenesin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pentam (5,686 reports)
- Guaifenesin (12,106 reports)
Browse all drug interactions of Pentam and Guaifenesin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pentam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Guaifenesin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pentam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Guaifenesin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pentamidine isethionate and guaifenesin (the active ingredients of Pentam and Guaifenesin, respectively), and Pentam and Guaifenesin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Mirena and Clindamycin Hydrochloride - now
- Drug interactions of Megace and Viagra - now
- Drug interactions of Hctz and Lialda - a second ago
- Could Saphnelo cause Death? - 20 seconds ago
- Could Ezetimibe cause Hyperthyroidism? - 24 seconds ago
- Drug interactions of Loraz and Optimark - 28 seconds ago
- Could Rabeprazole cause Nightmares? - 32 seconds ago
- Could Famvir cause Skin Abscess? - 37 seconds ago
- Could Lyrica cause Patient-Device Incompatibility? - 37 seconds ago
- Could Ultram cause Head Discomfort? - 43 seconds ago